SAKK 17/16 - Lurbinectedin as second or third line palliative chemotherapy in malignant pleural mesothelioma (MPM): A multi-center, single-arm phase II trial

Metaxas, Y.; Frueh, M.; Eboulet, E. I.; Grosso, F.; Pless, M.; Zucali, P. A.; Ceresoli, G. L.; Mark, M. T.; Schneider, M.; Roveta, A.; Perrino, M. R. A.; Biaggi Rudolf, C.; Froesch, P. R.; Schmidt, S.; Waibel, C.; Appenzeller, C.; Rauch, D.; von Moos, R.